We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

106 hedge funds and large institutions have $115M invested in Rigel Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

886% more call options, than puts

Call options by funds: $887K | Put options by funds: $90K

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

0.28% less ownership

Funds ownership: 6.37% → 6.09% (-0.28%)

10% less funds holding

Funds holding: 118 → 106 (-12)

20% less capital invested

Capital invested by funds: $143M → $115M (-$28M)

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
106
Holders Change
-12
Holders Change %
-10.17%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
34
Reduced
34
Closed
17
Calls
$887K
Puts
$90K
Net Calls
+$797K
Net Calls Change
-$206K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$3.75M
2
VOYA Investment Management
VOYA Investment Management
Georgia
+$1.39M
3
SCM
Soleus Capital Management
Connecticut
+$752K
4
GCP
GSA Capital Partners
United Kingdom
+$737K
5
BCM
Bridgeway Capital Management
Texas
+$264K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$2.49M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.79M
3
Millennium Management
Millennium Management
New York
-$1.66M
4
TA
Tamarack Advisers
California
-$1.61M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$85.2K +$18.2K +1,510 +24%
UBS Group
52
UBS Group
Switzerland
$84.4K -$43.4K -3,604 -32%
Franklin Resources
53
Franklin Resources
California
$75.7K -$133K -11,062 -61%
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$75.2K – – –
Prudential Financial
55
Prudential Financial
New Jersey
$66.8K – – –
Public Employees Retirement Association of Colorado
56
Public Employees Retirement Association of Colorado
Colorado
$50K – – –
Barclays
57
Barclays
United Kingdom
$45K -$4.63K -385 -8%
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$40.8K -$23.1K -1,917 -34%
N
59
Natixis
France
$40.5K -$23.8K -1,975 -34%
Wells Fargo
60
Wells Fargo
California
$40.4K -$43.9K -3,651 -49%
Marshall Wace
61
Marshall Wace
United Kingdom
$38.9K +$43.3K +3,602 New
BC
62
Burney Company
Virginia
$37.8K – – –
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$36.4K +$650 +54 +2%
SG Americas Securities
64
SG Americas Securities
New York
$34K +$37.9K +3,149 New
Mackenzie Financial
65
Mackenzie Financial
Ontario, Canada
$33.8K +$4.84K +402 +14%
GCM
66
Graham Capital Management
Connecticut
$32.5K -$62.1K -5,163 -63%
Vontobel Holding
67
Vontobel Holding
Switzerland
$32.4K – – –
JGC
68
J. Goldman & Co
New York
$32.2K – – –
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$30K +$13K +1,082 +67%
LPL Financial
70
LPL Financial
California
$29.3K – – –
PWA
71
Providence Wealth Advisors
Illinois
$29K – – –
AB
72
Amalgamated Bank
New York
$26K – – –
Jane Street
73
Jane Street
New York
$26K -$51.2K -4,255 -64%
DAS
74
Dynamic Advisor Solutions
Arizona
$25.2K +$3.61K +300 +15%
ProShare Advisors
75
ProShare Advisors
Maryland
$24K -$36 -3 -0.1%
1 2
3
4 5

RIGL Hedge Fund Activity: Q3 2023 in Review

106 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2023, worth a combined $115M — down 20% from $143M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of RIGL and 6 opened new positions — a net loss of 11 holders — while 34 trimmed existing stakes and 34 added.

The largest buyer was Morgan Stanley, adding an estimated $3.75M. The largest seller was Vanguard Group, cutting an estimated $2.49M.

  • 106 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2023, down from 118 in Q2 2023.
  • Funds reported $115M of Rigel Pharmaceuticals stock for Q3 2023, down 20% quarter-over-quarter.
  • 6 funds opened new Rigel Pharmaceuticals positions in Q3 2023 and 17 closed out, a net change of -11 holders.
  • The largest Rigel Pharmaceuticals buyer in Q3 2023 was Morgan Stanley, an estimated $3.75M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2023 was Vanguard Group, an estimated $2.49M sold.

Based on aggregated 13F filings for Q3 2023.